MIST Application Note

Regulatory agencies have made recommendations on when and how to identify and characterize drug metabolites to evaluate their non-clinical toxicity. Frontage has developed an approach that integrates a series of in vitro and in vivo assays to demonstrate due diligence in meeting MIST regulatory expectations.

"*" indicates required fields

First Name*

Last Name*

Company*

State*